The independent source for health policy research, polling, and news.
21 - 32 of 32 Results
Despite heavy opposition from the pharmaceutical industry and skepticism from policy experts, many voters see Proposition 61 as a way to protest the nation’s mounting drug prices.
Michael Weinstein of the AIDS Healthcare Foundation says he is promoting condoms where others have forgotten them.
Proposition 106, on Colorado's ballot next month, would allow doctors to prescribe a lethal dose of medication to people who have less than six months to live. A recent poll shows strong support for the measure.
When New York increased its cigarette tax, smoking rates declined. California's proposed increase of $2 a pack may, too, say researchers. The higher the tax, the more likely people are to quit.
As more states consider legalizing recreational marijuana, families consider what messages to present to young people about using pot. Should it be avoidance, moderation or acceptance? Differing views from Arizona and Oregon.
Recreational marijuana is on the ballot in five states in November. What do we know about pot's effects on the brain?
The initiative would prohibit California state agencies from paying more for a prescription drug than what the Department of Veterans Affairs pays. Both sides are deploying veterans’ sympathetic and trusted image to win over voters.
Proposition 52 would permanently enshrine a significant source of funding for hospitals and limit lawmakers’ ability to change it.
Health experts remain divided on legalizing marijuana for recreational use.
Staff researchers at California’s largest public buyer of health benefits say the goal of reducing drug costs for the state is appealing but might not work in the real world.
Heated battle expected over November ballot proposal to curb state’s prescription drug costs, as pharmaceutical industry opens its pocketbook to defeat the measure.
The group ColoradoCareYES gathered enough signatures — more than 100,000 — to put a single-payer health system on the ballot next fall. But the price tag is a worry to some.
© 2026 KFF